1H Magnetic Resonance Spectroscopy to Understand the Biological Basis of ALS, Diagnose Patients Earlier, and Monitor Disease Progression
At present, limited biomarkers exist to reliably understand, diagnose, and monitor the progression of amyotrophic lateral sclerosis (ALS), a fatal neurological disease characterized by motor neuron death. Standard MRI technology can only be used to exclude a diagnosis of ALS, but 1H-MRS technology,...
Main Authors: | Sarah Caldwell, Douglas L. Rothman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.701170/full |
Similar Items
-
Magnetic Resonance Spectroscopy in ALS
by: Sanjay Kalra
Published: (2019-05-01) -
Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy
by: Foteini Christidi, et al.
Published: (2022-04-01) -
Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study
by: Foteini Christidi, et al.
Published: (2023-02-01) -
Cortical glutamate and gamma-aminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study
by: Gerrit L.J. Onderwater, et al.
Published: (2021-01-01) -
Lessons of ALS imaging: Pitfalls and future directions — A critical review
by: Peter Bede, et al.
Published: (2014-01-01)